Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

388
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
388
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

541
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
541
Actuarial Approach01:20

Actuarial Approach

280
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
280
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

718
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
718
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

541
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
541
Hazard Rate01:11

Hazard Rate

383
The hazard rate, also known as the hazard function or failure rate, is a statistical measure used to describe the instantaneous rate at which an event occurs, given that the event has not yet happened. From a probabilistic perspective, it represents the likelihood that a subject will experience the event in a very small time interval, conditional on surviving up to the beginning of that interval. In terms of frequency, the hazard rate can be viewed as the ratio of the number of events to the...
383

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inverse Probability Weighting for Recurrent Event Models.

Statistics in medicine·2026
Same author

Improve the Precision of Area Under the Curve Estimation for Recurrent Events Through Covariate Adjustment.

Statistics in medicine·2025
Same author

A simple and robust parametric shared frailty model for recurrent events with the competing risk of death: An application to the Carvedilol Prospective Randomized Cumulative Survival trial.

Statistical methods in medical research·2024
Same author

Missing data and sensitivity analysis for binary data with implications for sample size and power of randomized clinical trials.

Statistics in medicine·2019
Same author

The microRNA miR-7a-5p ameliorates ischemic brain damage by repressing α-synuclein.

Science signaling·2018
Same journal

A Mixture of Distributed Lag Non-Linear Models to Account for Spatially Heterogeneous Exposure-Lag-Response Associations.

Statistics in medicine·2026
Same journal

Practical Considerations for Gaussian Process Modeling for Causal Inference in Quasi-Experimental Studies With Panel Data.

Statistics in medicine·2026
Same journal

Covariate Adjustment for Wilcoxon Two Sample Statistic and Test.

Statistics in medicine·2026
Same journal

Beyond Fixed Thresholds: Optimizing Summaries of Wearable Device Data via Piecewise Linearization of Quantile Functions.

Statistics in medicine·2026
Same journal

A Causal Framework for Evaluating the Total Effect of Strategies Aiming to Expand Screening and to Improve Outcomes.

Statistics in medicine·2026
Same journal

Causal Effects on Nonterminal Event Time With Application to Antibiotic Usage and Future Resistance.

Statistics in medicine·2026
See all related articles

Related Experiment Video

Updated: Jan 11, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K

Causal Inference for First Non-Fatal Events With the Competing Risk of Death: A Principal Stratification Approach.

Jiren Sun1, Thomas Cook1

  • 1Department of Biostatistics and Medical Informatics, University of Wisconsin-Madison, Madison, Wisconsin, USA.

Statistics in Medicine
|November 18, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces a new statistical model to accurately measure a treatment's direct effect on preventing nonfatal events, even when death is a competing risk. The proportional principal stratum hazards model provides a more precise understanding of treatment efficacy in clinical trials.

Keywords:
Cox proportional hazards modelcausal inferencecause‐specific hazard ratioprincipal stratificationsemi‐competing risksshared frailty model

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

Related Experiment Videos

Last Updated: Jan 11, 2026

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.7K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

Area of Science:

  • Biostatistics
  • Clinical Trials Methodology
  • Survival Analysis

Background:

  • Active treatments can directly or indirectly affect nonfatal events in clinical trials with competing risks.
  • Standard Cox models may misestimate direct treatment effects on nonfatal events due to the competing risk of death.

Purpose of the Study:

  • To develop a statistical framework to isolate and estimate the direct effect of an active treatment on the underlying nonfatal event process.
  • Introduce the proportional principal stratum hazards model for accurate estimation in the presence of competing risks.

Main Methods:

  • Utilized the principal stratification framework to define principal stratum hazards.
  • Introduced the proportional principal stratum hazards model to estimate the principal stratum hazard ratio.
  • Employed a shared frailty model for probabilistic identification of principal stratum membership.

Main Results:

  • The proposed model estimates the principal stratum hazard ratio, reflecting the direct treatment effect on the nonfatal event process.
  • This ratio simplifies to the standard hazard ratio when death is not a competing risk.
  • Simulation studies confirmed the reliability of the developed estimators.

Conclusions:

  • The proportional principal stratum hazards model offers a robust method for assessing the direct impact of treatments on morbidity in the presence of mortality.
  • This approach enhances the interpretation of treatment effects in complex clinical trial settings, as demonstrated in the Carvedilol trial.